Dexcom Inc.
0
0
0%

Statistics

Valuation metrics
Market cap
21.69B
Enterprise value
18.43B
Trailing P/E (ttm)
36.77
Forward P/E
PEG ratio
Price/Sales (ttm)
4.95
Price/Book (mrq)
9.51
Enterprise Value/Revenue
4.79
Enterprise Value/EBITDA
21.16
Overview
Shares outstanding
390M
Float
387.42M
Shares short
% Held by insiders
0.42%
% Held by institutions
99.70%
Average volume (10 days)
16
Average volume (90 days)
16
Price summary
52-Week low
47.32
52-Week high
87.21
52-Week change
-30.85
Beta
1.52
50-Day moving average
55.04
200-Day moving average
64.85
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
15.96%
Operating margin
20.05%
Operational effectiveness
Return on assets
7.02%
Return on equity
30.64%
Income statement
Revenue (ttm)
3.85B
Revenue per share (ttm)
11.54
Quarterly revenue growth (yoy)
21.60%
Gross profit (ttm)
2.27B
EBITDA
1.04B
Net income to common (ttm)
614.22M
Diluted EPS (ttm)
1.54
Quarterly earnings growth (yoy)
110.80%
Balance sheet
Total cash (mrq)
2.83B
Total cash per share (mrq)
8.52
Total debt (mrq)
2.20B
Total Debt/Equity (mrq)
94.48
Current ratio (mrq)
156.50%
Book value per share (mrq)
5.96
Cash flow
Cash flow statement
1.23B
Levered free cash flow (LFCF)
667.64M
Access /statistics data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 3 hours 49 minutes

13:45
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).